Home Cart 0 Sign in  
X

[ CAS No. 260806-90-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 260806-90-4
Chemical Structure| 260806-90-4
Chemical Structure| 260806-90-4
Structure of 260806-90-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 260806-90-4 ]

Related Doc. of [ 260806-90-4 ]

Alternatived Products of [ 260806-90-4 ]

Product Details of [ 260806-90-4 ]

CAS No. :260806-90-4 MDL No. :MFCD11042778
Formula : C9H9BrO3 Boiling Point : -
Linear Structure Formula :- InChI Key :YMRGVTKIFLNUFC-UHFFFAOYSA-N
M.W : 245.07 Pubchem ID :46311082
Synonyms :

Calculated chemistry of [ 260806-90-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.91
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.41
Log Po/w (XLOGP3) : 2.73
Log Po/w (WLOGP) : 2.24
Log Po/w (MLOGP) : 2.36
Log Po/w (SILICOS-IT) : 2.39
Consensus Log Po/w : 2.42

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.22
Solubility : 0.147 mg/ml ; 0.000599 mol/l
Class : Soluble
Log S (Ali) : -3.13
Solubility : 0.182 mg/ml ; 0.000741 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.46
Solubility : 0.085 mg/ml ; 0.000347 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 260806-90-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 260806-90-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 260806-90-4 ]
  • Downstream synthetic route of [ 260806-90-4 ]

[ 260806-90-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 260806-90-4 ]
  • [ 101084-39-3 ]
Reference: [1] Liebigs Annalen der Chemie, 1989, p. 863 - 882
  • 2
  • [ 67-56-1 ]
  • [ 101084-39-3 ]
  • [ 260806-90-4 ]
YieldReaction ConditionsOperation in experiment
99% for 24 h; Reflux General procedure: The benzoic acid (1-4 g)was dissolved in methanol (25-75 mL),before conc. H2SO4 (2-6 mL) was added dropwise while stirring.The reaction mixture was heated to reflux and stirred for 24 h. Thereaction mixture was quenched in a saturated aq NaHCO3 solution(100-200 mL) ensuring neutral to basic pH, and the aqueous phase was extracted with CH2Cl2 (4 x 50 mL). The combined organic phases were washed with saturated aq NaCl solution (25-50 mL),dried over anhydrous Na2SO4 and filtered. Concentration yielded the target compound in high yield and purity. ;Methyl 3-bromo-2-methoxybenzoate was prepared as described in Section
4.5
, starting with 3-bromo-2-methoxybenzoic acid (1.00 g, 4.33 mmol).
The procedure yielded 1.07 g (4.33 mmol, 100percent) of methyl 3-bromo-2-methoxybenzoate as clear oil, HPLC-purity: 99percent, tR = 21.5 min; 1H NMR (600 MHz, DMSO-d6) δ: 7.88-7.84 (m, 1H), 7.73-7.70 (m, 1H), 7.18 (t, J = 7.8, 1H), 3.86 (s, 3H), 3.81 (s, 3H); 13C NMR (150 MHz, DMSO-d6) δ: 165.1, 155.7, 137.0, 130.3, 126.8, 125.6, 118.1, 61.8, 51.4; HRMS (APCI/ASAP, m/z): 244.9813 (calcd. C9H1079BrO3, 244.9813, [M+H]+).
1H NMR data are in accordance with that reported previously
90% With pyridine; oxalyl dichloride In dichloromethane at 20℃; 3-Bromo-2-methoxybenzoic acid (2 g, 8.65 mmol, 1.0 eq) was dissolved in dry DCM and stirred for 10 minutes, cooled to 0 °C and slowly treated with oxalyl chloride (3.3 g, 25.9 mmol, 3 eq). Methanol in pyridine was added dropwise and the reaction mixture was stirred at ambient temperature. The solvents were evaporated under reduced pressure and the reaction mass was diluted with water. The aqueous mixture was extracted with ethyl acetate. The organic layer was dried with anhydrous Na2SO4 and concentrated under vacuum to afford the desired product (1.9 g, 90percent). 1H NMR (400 MHz, CDCl3) δ 3.93 (s, 6H), 7.02-6.06 (t, 1H), 7.72-7.76 (m, 2H). MS (ESI): 247.0 (M + H)+.
60% Reflux Concentrated sulphuric acid (2.0 ml) was slowly added to a solution of the commercially available 3-bromo-2-methoxybenzoic acid 23 (2.0 g, 8.66 mmol) in methanol (40.0 ml), and the mixture was refluxed overnight. Then the mixture was allowed to cool to room temperature and neutralized with saturated aqueous sodium bicarbonate solution. The aqueous layer was extracted several times with ethyl acetate, and the combined organic phases were dried over anhydrous Na2SO4, filtered and concentrated in vacuo to give pure 24 in 60percent yield. 1H NMR (200 MHz, CDCl3) δ (ppm): 3.92 (s, 6H), 7.03 (t, 1H, J = 7.9 Hz), 7.70 (dd, 1H, J = 6.4 Hz, J = 1.6 Hz), 7.74 (dd, 1H, J = 6.4 Hz, J = 1.6 Hz); MS: m/z 245 (M+, 100), 247 ([M + 2]+, 88), 214 ([M - OCH3]+, 72), 216 ([M + 2 - OCH3]+, 57).
Reference: [1] European Journal of Medicinal Chemistry, 2016, vol. 107, p. 255 - 274
[2] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 24, p. 3447 - 3452
[3] Patent: WO2009/152082, 2009, A1, . Location in patent: Page/Page column 198
[4] European Journal of Medicinal Chemistry, 2014, vol. 90, p. 526 - 536
[5] Patent: US2008/194650, 2008, A1, . Location in patent: Page/Page column 22-23
[6] Patent: US2009/306161, 2009, A1, . Location in patent: Page/Page column 8-9
  • 3
  • [ 3883-95-2 ]
  • [ 77-78-1 ]
  • [ 260806-90-4 ]
Reference: [1] Liebigs Annalen der Chemie, 1989, p. 863 - 882
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 260806-90-4 ]

Aryls

Chemical Structure| 139102-34-4

[ 139102-34-4 ]

Methyl 4-bromo-2-methoxybenzoate

Similarity: 0.95

Chemical Structure| 17100-63-9

[ 17100-63-9 ]

Methyl 4-bromo-3-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26050-64-6

[ 26050-64-6 ]

Methyl 4-bromo-3,5-dimethoxybenzoate

Similarity: 0.92

Chemical Structure| 1131587-94-4

[ 1131587-94-4 ]

Methyl 5-bromo-4-methoxy-2-methylbenzoate

Similarity: 0.92

Chemical Structure| 72135-36-5

[ 72135-36-5 ]

4-Bromo-2-methoxybenzoic acid

Similarity: 0.92

Bromides

Chemical Structure| 139102-34-4

[ 139102-34-4 ]

Methyl 4-bromo-2-methoxybenzoate

Similarity: 0.95

Chemical Structure| 17100-63-9

[ 17100-63-9 ]

Methyl 4-bromo-3-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26050-64-6

[ 26050-64-6 ]

Methyl 4-bromo-3,5-dimethoxybenzoate

Similarity: 0.92

Chemical Structure| 1131587-94-4

[ 1131587-94-4 ]

Methyl 5-bromo-4-methoxy-2-methylbenzoate

Similarity: 0.92

Chemical Structure| 72135-36-5

[ 72135-36-5 ]

4-Bromo-2-methoxybenzoic acid

Similarity: 0.92

Ethers

Chemical Structure| 139102-34-4

[ 139102-34-4 ]

Methyl 4-bromo-2-methoxybenzoate

Similarity: 0.95

Chemical Structure| 17100-63-9

[ 17100-63-9 ]

Methyl 4-bromo-3-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26050-64-6

[ 26050-64-6 ]

Methyl 4-bromo-3,5-dimethoxybenzoate

Similarity: 0.92

Chemical Structure| 1131587-94-4

[ 1131587-94-4 ]

Methyl 5-bromo-4-methoxy-2-methylbenzoate

Similarity: 0.92

Chemical Structure| 72135-36-5

[ 72135-36-5 ]

4-Bromo-2-methoxybenzoic acid

Similarity: 0.92

Esters

Chemical Structure| 139102-34-4

[ 139102-34-4 ]

Methyl 4-bromo-2-methoxybenzoate

Similarity: 0.95

Chemical Structure| 17100-63-9

[ 17100-63-9 ]

Methyl 4-bromo-3-methoxybenzoate

Similarity: 0.93

Chemical Structure| 26050-64-6

[ 26050-64-6 ]

Methyl 4-bromo-3,5-dimethoxybenzoate

Similarity: 0.92

Chemical Structure| 1131587-94-4

[ 1131587-94-4 ]

Methyl 5-bromo-4-methoxy-2-methylbenzoate

Similarity: 0.92

Chemical Structure| 71337-53-6

[ 71337-53-6 ]

(E)-2,2'-(Fumaroylbis(oxy))bis(3,5-dibromobenzoic acid)

Similarity: 0.91